310 likes | 558 Views
Fluid Resuscitation in Traumatic Critically Ill Patients. Aug 21, 2006 Ri 林 殿 閔. Patterns of Traumatic Injury. Penetrating injury – ongoing significant blood loss is expected Blunt injury – blood loss may be occult or contained and significant or limited
E N D
Fluid Resuscitation in Traumatic Critically Ill Patients Aug 21, 2006 Ri 林 殿 閔
Patterns of Traumatic Injury • Penetrating injury – ongoing significant blood loss is expected • Blunt injury – blood loss may be occult or contained and significant or limited • Head injury – maintenance of cerebral perfusion pressure • Others: pediatric and obstetric trauma
Shock • Definition: a state of reduced organ perfusion resulting in tissue hypoxia and organ dysfunction • S/S: falling of BP, tachycardia, oligouria, decreased mental status, decreased peripheral pulses, diaphoresis • Main goal of therapy: rapid resuscitation with re-establishment of tissue perfusion using fluid therapy and vasoactive drugs
Hemorrhagic shock • Acute response: • Increased capillary permeability • Reduction in blood flow • Sympathetic compensation by peripheral vasoconstriction • Elevated IL-6 and TNF-alpha • Tissue hypoperfusion and anaerobic metabolism/acidosis • After systemic circulation is restored, reperfusion injury due to free oxygen radicals released during acute hypoxic stage may occur
Traumatic hemorrhagic shock • Acute stage: hemorrhagic shock • May be accompanied with : • Cardiogenic shock • Neurogenic shock • Obstructive shock • Septic shock
Traumatic hemorrhagic shock • Trauma triad of death after hemorrhagic shock: (1) Hypothermia (2) Acidosis (3) Coagulopathy
Traumatic hemorrhagic shock • Phase 1: The period from injury to definite surgical care and homeostasis • Phase 2: The period during and immediately after definite surgical procedure • Phase 3: The period in ICU following definitive care and characterized by established critical illness
Phase 1: pre-hospital /pre-operative fluid therapy • Traumatic hypotension without a head injury: no evidence suggest that pre-hospital fluids are beneficial • Delayed fluid resuscitation has better outcome than immediate resuscitation in penetrating torso injuries • The evidence supporting delayed or limited prehospital resuscitation in blunt trauma is less clear
Phase 2: perioperative fluid management • It is unclear whether targeting cardiac output or oxygen delivery to specific defined goals results in improved clinical outcomes • Maximized stroke volume using fluids titrated against a measure of blood flow is supported by limited available data
Phase 2: perioperative fluid anagement • The addition of inotropes to achieve specific blood flow or oxygen delivery goals may confer additional advantage but the available data is not conclusive
Phase 3: Critical care fluid management • Fluid strategies are directed at restoring organ function after the combined insult of hypovolemic hypoperfusion, surgery and trauma induced inflammatory response • Maintaining a normal circulating volume (cardiac output) is a priority • Targeting oxygen delivery goals has been demonstrated to be harmful in established critical illness
Trauma Fluid Resuscitation • Severity of hemorrhagic shock • Age • Co-morbid disorder • Injury types • Concurrent head or spinal injury • Pulmonary edema
Types of Fluid • Crystalloid solutions • Colloid solutions • Gelatins • Dextrans • Hydroxyethyl starches (HES) • Albumin and plasma-protein fraction • Blood & blood substitutes
Crystalloids • Solutions in water of inorganic ions and small organic molecules, either glucose or sodium chloride based.
Colloids • A homogeneous, non-crystalline substance consisting of large molecules or ultramicroscopic particles of one substance dispersed through a second substance • Principal types of semisynthetic colloid molecules: gelatins; dextrans; and HES • Human plasma derivatives: albumin, FFP and immunoglobulin solutions
Key characteristics of artificial colloids • Magnitude and duration of plasma volume expansion • Hemorreological characteristics • Hemostatic effects • Interaction with endothelial and inflammatory cells • Adverse drug reactions • Cost
Gelatins, Dextrans, HES • Gelatins: prepared by hydrolysisof bovine collagen. commonly available preparation -- succinylated gelatin (Gelofusin) • Dextrans: high-MW D-glucose polymers joined largely into linear-branched macromolecules • HES: synthesized from amylopectin, a waxy starch derived from maize or sorghum
Albumin and plasma-protein fraction • Human albumin: a naturally occuring monodiperse colloid • FFP and plasma-protein fraction: a more polydisperse human-derived colloidal solution with significant amounts of higher-MW proteins -- globulins
Blood Substitutes: hemoglobulin solutions • At an early stage of development and probably some way from routine clinical use • HBOC (Hemoglobic-based oxygen-carrying compounds) • PBOC (Perflourocarbon-based oxygen-carrying compounds) • Have a linear O2Hb dissociation profile and specific pharmacological effects